EUDA Health Holdings Research and Development Expenses 2022-2023 | EUDA

EUDA Health Holdings research and development expenses from 2022 to 2023. Research and development expenses can be defined as an expense arising from studies and product development processes.
EUDA Health Holdings Annual Research and Development Expenses
(Millions of US $)
2023 $
2022 $
2021 $0
EUDA Health Holdings Quarterly Research and Development Expenses
(Millions of US $)
2023-06-30
2023-03-31
2022-12-31
2022-03-31 $0
2021-12-31
2021-10-31
Sector Industry Market Cap Revenue
Medical Medical Information Systems $0.065B $0.004B
EUDA Health Limited is a health technology company which operates southeast Asian digital healthcare ecosystem. The company's proprietary unified AI platform quickly assesses a patient's medical history, triages a condition, digitally connects patients with clinicians and predicts optimal treatment outcomes. Its holistic approach supports patients throughout all stages of care, including wellness and prevention, urgent care and emergencies, pre-existing conditions and aftercare services. EUDA Health Limited, formerly known as 8i Acquisition 2 Corp., is based in Singapore.
Stock Name Country Market Cap PE Ratio
GE HealthCare Technologies (GEHC) United States $35.810B 19.66
Inspire Medical Systems (INSP) United States $4.766B 0.00
Hims & Hers Health (HIMS) United States $4.206B 0.00
Axonics (AXNX) United States $3.419B 0.00
Olink Holding AB (publ) (OLK) Sweden $2.988B 0.00
Azenta (AZTA) United States $2.744B 154.24
Enovis (ENOV) United States $2.713B 20.11
IRhythm Technologies (IRTC) United States $2.698B 0.00
10x Genomics (TXG) United States $2.635B 0.00
Privia Health (PRVA) United States $1.957B 109.33
Schrodinger (SDGR) United States $1.556B 0.00
Omnicell (OMCL) United States $1.461B 50.49
Phreesia (PHR) United States $1.251B 0.00
Standard BioTools (LAB) United States $0.965B 0.00
Definitive Healthcare (DH) United States $0.625B 0.00
Fulgent Genetics (FLGT) United States $0.624B 0.00
Clover Health Investments (CLOV) United States $0.511B 0.00
Talkspace (TALK) United States $0.453B 0.00
Health Catalyst (HCAT) United States $0.386B 0.00
SOPHiA GENETICS SA (SOPH) Switzerland $0.336B 0.00
Pulmonx (LUNG) United States $0.292B 0.00
Butterfly Network (BFLY) United States $0.211B 0.00
Outset Medical (OM) United States $0.197B 0.00
P3 Health Partners (PIII) United States $0.172B 0.00
TruBridge (TBRG) United States $0.139B 7.46
American Well (AMWL) United States $0.123B 0.00
111 (YI) China $0.105B 0.00
MSP Recovery (LIFW) United States $0.100B 0.00
SHL Telemedicine (SHLT) Israel $0.080B 0.00
HeartBeam (BEAT) United States $0.077B 0.00
Future Health ESG (FHLT) United States $0.065B 0.00
Augmedix (AUGX) United States $0.056B 0.00
Mobile-health Network Solutions (MNDR) Singapore $0.054B 0.00
CareCloud (CCLD) United States $0.046B 0.00
Zepp Health (ZEPP) China $0.045B 0.00
Movano (MOVE) United States $0.037B 0.00
Akili (AKLI) United States $0.033B 0.00
ImmunoPrecise Antibodies (IPA) Canada $0.029B 0.00
Streamline Health Solutions (STRM) United States $0.026B 0.00
Bullfrog AI Holdings (BFRG) United States $0.021B 0.00
Strata Skin Sciences (SSKN) United States $0.013B 0.00
Biotricity (BTCY) United States $0.011B 0.00
Syra Health (SYRA) United States $0.009B 0.00
Transgenomic (PRPO) United States $0.009B 0.00
Cue Health (HLTH) United States $0.009B 0.00
Predictive Oncology (POAI) United States $0.008B 0.00
HeartSciences (HSCS) United States $0.004B 0.00
Healthcare Triangle (HCTI) United States $0.004B 0.00
Tivic Health Systems (TIVC) United States $0.003B 0.00
Zhongchao (ZCMD) China $0.003B 0.00
Centogene (CNTG) Germany $0.000B 0.00
MDxHealth SA (MDXH) Belgium $0.000B 0.00
Nyxoah SA (NYXH) Belgium $0.000B 0.00